カテゴリー： Grand View Research, 世界, 医療/バイオ

がんワクチンの世界市場2023-2030：市場規模、シェア、動向分析

◆英語タイトル：Cancer Vaccine Market Size, Share & Trends Analysis Report By Indication Type (Bladder, Cervical), By Vaccine Type (Preventive, Therapeutic), By Technology Type (Recombinant, Whole-cell), By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが発行した調査報告書（GRV23AUG057）◆商品コード：GRV23AUG057
◆発行会社（リサーチ会社）：Grand View Research
◆発行日：2023年7月25日
◆ページ数：130
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

がんワクチン市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界のがんワクチン市場規模は2023年から2030年にかけて年平均成長率11.04%で拡大し、2030年には168億4000万米ドルに達する見込みです。市場成長の背景には、人口の間でがんの有病率が増加していることがあります。WHOによると、がんは世界的に主要な死因であり、2020年には1,000万人が死亡し、前立腺がん、肺がん、乳がん、結腸がん、皮膚がん、胃がんなどが最も多く、世界では6人に1人が死亡しています。症例数の増加は、高齢者人口の増加や、経済・社会の発展に伴う特定のがん原因の有病率の変化など、さまざまな要因によるところが大きい。これは特に新興経済圏で見られ、貧困に関連したがんという点では一般的な変化が観察され、先進経済圏では生活習慣の乱れに関連した症例が増えているのとは対照的です。

WHOによると、肥満、ある種の感染症、放射線被曝は、患者数の増加に関連する主な要因です。さらに、予防分野における技術の進歩により、ワクチンの需要は世界的に大幅に増加しています。バイオマーカーおよびマスサイトメトリーの開発に対するFDAの支援、創薬および診断のためのさまざまなフローサイトメトリー試薬の発売、携帯性と精度を容易にする技術的に進歩した小型化装置、細胞およびビーズベースのフローサイトメトリー技術の開発は、市場の成長を後押しする主な要因です。革新的なワクチンの需要が世界的に高まっている主な要因は、がんに対する認識を高めるための各種団体によるプログラムです。子宮頸がんの検診を増やすために全米子宮頸がん連合、CDC、WHO、米国予防サービス専門委員会（U.S. Preventive Services Task Force）などが行っている協力関係やパートナーシップは、予測期間中に市場の成長を増大させると予想される主な要因です。

さらに、各種ワクチンの開発・製剤化に携わる主要企業は、新規ワクチンの開発や業界における競争力の維持のため、共同研究や提携に注力しています。さらに、この疾患の予防需要の高まりに対応するため、複数の企業が新規ワクチンの開発に取り組んでいます。例えば、2023年2月、BioNTech社は、2023年9月からワクチンの臨床試験を開始する計画を発表しました。2023年3月には、クリーブランド・クリニックの研究者が、最も致死率の高いトリプルネガティブ乳がんの予防ワクチンの上市に向けた次のステップを発表しました。

がんワクチン市場レポートハイライト

- 有病率の上昇に伴う疾患予防の必要性から、予防ワクチンタイプが2022年に最大の売上シェアを獲得しました。

- 子宮頸がん適応症タイプは、有病率の上昇により予測期間中に最も速い成長率を記録する見込みです。

- 技術タイプ別では、組換え技術から開発されたワクチンの入手可能性が高いことから、組換えワクチン分野が2022年の世界産業を独占しました。

- 主要企業は、市場での地位とシェアを維持するため、製品の上市と地理的拡大に絶えず注力しています。

- 医療インフラが整備されていること、がんの有病率が高いこと、主要企業が存在すること、適切なワクチン接種サービスが利用可能であることから、2022年には北米が最大の売上シェアを占めました。

第1章. がんワクチン市場：調査手法＆範囲
第2章. がんワクチン市場：エグゼクティブサマリー
第3章. がんワクチン市場：産業動向
第4章. がんワクチン市場：競争状況
第5章. がんワクチン市場：ワクチンタイプ別分析
第6章. がんワクチン市場：疾患別分析
第7章. がんワクチン市場：技術タイプ別分析
第8章. がんワクチン市場：地域別分析
第9章. がんワクチン市場：企業情報

❖ レポートの目次 ❖

Table of Contents

Chapter 1 Cancer Vaccine Market: Methodology And Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Definitions
1.1.1.1 Vaccine Type Segment
1.1.1.2 Technology type segment
1.1.1.3 Indication type segment
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Objectives
1.4.1 Objective – 1
1.4.2 Objective – 2
1.4.3 Objective – 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Gvr’s Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information Or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List of Secondary Sources
1.11 List of Abbreviations
Chapter 2 Cancer Vaccine Market: Executive Summary
2.1 Market Snapshot
2.2 Vaccine Type and Indication Type Snapshot
2.3 Technology Type Snapshot
2.4 Competitive Landscape Snapshot
Chapter 3 Cancer Vaccine Market: Industry Outlook
3.1 Market Lineage Outlook
3.1.1 Parent Market Lineage Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Drivers
3.3.1.1 Increasing Prevalence of cancer
3.3.1.2 Growing investments and governmental funding in the development of cancer vaccines
3.3.1.3 Increasing demand for cancer vaccines
3.3.1.4 Launch of new cancer vaccines
3.3.2 Market Restraint Analysis
3.3.2.1 Complex And Time-Consuming Regulatory Approval Process
3.3.2.2 High Price Associated With Vaccines
3.4 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.5 Industry Analysis – Porter’s
3.6 Reimbursement & Regulatory Scenario
3.7 Major Deals & Strategic Alliances
3.7.1 New Product Launch
3.7.2 Acquisition
3.7.3 Expansion
3.7.4 Partnerships
3.7.5 Marketing & Promotions
Chapter 4 Cancer Vaccine Market: Competitive Landscape
4.1 Recent developments & impact analysis, by key market participants
4.1.1 Ansoff Matrix
4.2 Company Categorization
4.2.1 Innovators
4.2.1.1 Market Differentiators
4.3 Vendor Landscape
4.3.1 List Of Key Distributors And Channel Partners
4.3.2 Key Customers
4.3.3 Key Company Market Share Analysis, 2022
4.4 Public Companies
4.4.1 Competitive Dashboard Analysis
4.5 Private Companies
4.5.1 List Of Key Emerging Companies
4.6 Regional Network Map
Chapter 5 Cancer Vaccine Market: Vaccine Type Business Analysis
5.1 Definition And Scope
5.2 Vaccine Type Market Share Analysis, 2022 & 2030
5.3 Global Cancer Vaccine Market, By Vaccine Type, 2018 To 2030
5.4 Cancer Vaccine Market: Vaccine Type Movement Analysis
5.5 Preventive Cancer Vaccines
5.5.1 Preventive Cancer Vaccines Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.6 Therapeutic Cancer Vaccines
5.6.1 Therapeutic Cancer Vaccines Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.7 Others
5.7.1 Others Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 6 Cancer Vaccine Market: Indication Type Business Analysis
6.1 Definition And Scope
6.2 Indication Type Market Share Analysis, 2022 & 2030
6.3 Global Cancer Vaccine Market, By Indication Type, 2018 To 2030
6.4 Cancer Vaccine Market: Indication Type Movement Analysis
6.5 Prostate Cancer
6.5.1 Prostate Cancer Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.6 Bladder Cancer
6.6.1 Bladder Cancer Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.7 Melanoma
6.7.1 Melanoma Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.8 Cervical Cancer
6.8.1 Cervical Cancer Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.9 Others
6.9.1 Others Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 7 Cancer Vaccine Market: Technology Type Business Analysis
7.1 Definition And Scope
7.2 Technology Type Market Share Analysis, 2022 & 2030
7.3 Global Cancer Vaccine Market, By Technology Type, 2018 To 2030
7.4 Cancer Vaccine Market: Technology Type Movement Analysis
7.5 Recombinant Cancer Vaccines
7.5.1 Recombinant Cancer Vaccines Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.6 Whole-Cell Cancer Vaccines
7.6.1 Whole-Cell Cancer Vaccines Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.7 Viral Vector And Dna Cancer Vaccines
7.7.1 Viral Vector And Dna Cancer Vaccines Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.8 Others
7.8.1 Others Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 8 Cancer Vaccine Market: Regional Business Analysis
8.1 Definition & Scope
8.2 Regional Market Share Analysis, 2022 & 2030
8.3 Regional Market Dashboard
8.4 Regional Market Snapshot
8.5 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
8.5.1 North America
8.5.2 Europe
8.5.3 Asia Pacific
8.5.4 Latin America
8.5.5 Mea
8.6 Market Size, & Forecasts, Trend Analysis, 2022 To 2030
8.7 North America
8.7.1 North America Cancer Vaccine Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.7.2 U.S.
8.7.2.1 U.S. Cancer Vaccine Market, 2018 – 2030 (USD Million)
8.7.2.2 Key Country Dynamics
8.7.2.3 Regulatory Framework
8.7.2.4 Competitive Scenario
8.7.3 Canada
8.7.3.1 Canada Cancer Vaccine Market, 2018 – 2030 (USD Million)
8.7.3.2 Key Country Dynamics
8.7.3.3 Regulatory Framework
8.7.3.4 Competitive Scenario
8.8 Europe
8.8.1 Europe Cancer Vaccine Market, 2018 – 2030 (USD Million)
8.8.2 UK
8.8.2.1 UK Cancer Vaccine Market, 2018 – 2030 (USD Million)
8.8.2.2 Key Country Dynamics
8.8.2.3 Regulatory Framework
8.8.2.4 Competitive Scenario
8.8.3 Germany
8.8.3.1 Germany Cancer Vaccine Market, 2018 – 2030 (USD Million)
8.8.3.2 Key Country Dynamics
8.8.3.3 Regulatory Framework
8.8.3.4 Competitive Scenario
8.8.4 Spain
8.8.4.1 Spain Cancer Vaccine Market, 2018 – 2030 (USD Million)
8.8.4.2 Key Country Dynamics
8.8.4.3 Regulatory Framework
8.8.4.4 Competitive Scenario
8.8.5 France
8.8.5.1 France Cancer Vaccine Market, 2018 – 2030 (USD Million)
8.8.5.2 Key Country Dynamics
8.8.5.3 Regulatory Framework
8.8.5.4 Competitive Scenario
8.8.6 Italy
8.8.6.1 Italy Cancer Vaccine Market, 2018 – 2030 (USD Million)
8.8.6.2 Key Country Dynamics
8.8.6.3 Regulatory Framework
8.8.6.4 Competitive Scenario
8.8.7 Norway
8.8.7.1 Norway Cancer Vaccine Market, 2018 – 2030 (USD Million)
8.8.7.3 Regulatory Framework
8.8.7.4 Competitive Scenario
8.8.8 Denmark
8.8.8.1 Denmark Cancer Vaccine Market, 2018 – 2030 (USD Million)
8.8.8.2 Key Country Dynamics
8.8.8.3 Regulatory Framework
8.8.8.4 Competitive Scenario
8.8.9 Sweden
8.8.9.1 Sweden Cancer Vaccine Market, 2018 – 2030 (USD Million)
8.8.9.2 Key Country Dynamics
8.8.9.3 Regulatory Framework
8.8.9.4 Competitive Scenario
8.9 Asia Pacific
8.9.1 Asia-Pacific Cancer Vaccine Market, 2018 – 2030 (USD Million)
8.9.2 Japan
8.9.2.1 Japan Cancer Vaccine Market, 2018 – 2030 (USD Million)
8.9.2.2 Key Country Dynamics
8.9.2.3 Regulatory Framework
8.9.2.4 Competitive Scenario
8.9.3 China
8.9.3.1 China Cancer Vaccine Market, 2018 – 2030 (USD Million)
8.9.3.2 Key Country Dynamics
8.9.3.3 Regulatory Framework
8.9.3.4 Competitive Scenario
8.9.4 India
8.9.4.1 India Cancer Vaccine Market, 2018 – 2030 (USD Million)
8.9.4.2 Key Country Dynamics
8.9.4.3 Regulatory Framework
8.9.4.4 Competitive Scenario
8.9.5 South Korea
8.9.5.1 South Korea Cancer Vaccine Market, 2018 – 2030 (USD Million)
8.9.5.2 Key Country Dynamics
8.9.5.3 Regulatory Framework
8.9.5.4 Competitive Scenario
8.9.6 Thailand
8.9.6.1 Thailand Cancer Vaccine Market, 2018 – 2030 (USD Million)
8.9.6.2 Key Country Dynamics
8.9.6.3 Regulatory Framework
8.9.6.4 Competitive Scenario
8.9.7 Australia
8.9.7.1 Australia Cancer Vaccine Market, 2018 – 2030 (USD Million)
8.9.7.2 Key Country Dynamics
8.9.7.3 Regulatory Framework
8.9.7.4 Competitive Scenario
8.10 Latin America
8.10.1 Latin America Cancer Vaccine Market, 2018 – 2030 (USD Million)
8.10.2 Brazil
8.10.2.1 Brazil Cancer Vaccine Market, 2018 – 2030 (USD Million)
8.10.2.2 Key Country Dynamics
8.10.2.3 Regulatory Framework
8.10.2.4 Competitive Scenario
8.10.3 Mexico
8.10.3.1 Mexico Cancer Vaccine Market, 2018 – 2030 (USD Million)
8.10.3.2 Key Country Dynamics
8.10.3.3 Regulatory Framework
8.10.3.4 Competitive Scenario
8.10.4 Argentina
8.10.4.1 Argentina Cancer Vaccine Market, 2018 – 2030 (USD Million)
8.10.4.2 Key Country Dynamics
8.10.4.3 Regulatory Framework
8.10.4.4 Competitive Scenario
8.11 MEA
8.11.1 MEA Cancer Vaccine Market, 2018 – 2030 (USD Million)
8.11.2 South Africa
8.11.2.1 South Africa Cancer Vaccine Market, 2018 – 2030 (USD Million)
8.11.2.2 Key Country Dynamics
8.11.2.3 Regulatory Framework
8.11.2.4 Competitive Scenario
8.11.3 Saudi Arabia
8.11.3.1 Saudi Arabia Cancer Vaccine Market, 2018 – 2030 (USD Million)
8.11.3.2 Key Country Dynamics
8.11.3.3 Regulatory Framework
8.11.3.4 Competitive Scenario
8.11.4 UAE
8.11.4.1 UAE Cancer Vaccine Market, 2018 – 2030 (USD Million)
8.11.4.2 Key Country Dynamics
8.11.4.3 Regulatory Framework
8.11.4.4 Competitive Scenario
8.11.5 Kuwait
8.11.5.1 Kuwait Cancer Vaccine Market, 2018 – 2030 (USD Million)
8.11.5.2 Key Country Dynamics
8.11.5.3 Regulatory Framework
8.11.5.4 Competitive Scenario
Chapter 9 Cancer Vaccine Market: Company Profiling
9.1 Company Categorization
9.2 Strategy Mapping
9.2.1 New Product Launch
9.2.2 Partnerships
9.2.3 Acquisition
9.2.4 Collaboration
9.2.5 Funding
9.3 Key Company Market Share Analysis, 2022
9.4 Company Profiles
9.4.1 Merck & Co., Inc.
9.4.1.1 Company Overview
9.4.1.2 Financial Performance
9.4.1.3 Product Benchmarking
9.4.1.4 Strategic Initiatives
9.4.2 GSK plc
9.4.2.1 Company Overview
9.4.2.2 Financial Performance
9.4.2.3 Product Benchmarking
9.4.2.4 Strategic Initiatives
9.4.3 Dendreon Pharmaceuticals LLC.
9.4.3.1 Company Overview
9.4.3.2 Product Benchmarking
9.4.3.3 Strategic Initiatives
9.4.4 Dynavax Technologies.
9.4.4.1 Company Overview
9.4.4.2 Financial Performance
9.4.4.3 Product Benchmarking
9.4.4.4 Strategic Initiatives
9.4.5 Ferring B.V.
9.4.5.1 Company Overview
9.4.5.2 Financial Performance
9.4.5.3 Product Benchmarking
9.4.5.4 Strategic Initiatives
9.4.6 Amgen, Inc.
9.4.6.1 Company Overview
9.4.6.2 Financial Performance
9.4.6.3 Product Benchmarking
9.4.6.4 Strategic Initiatives
9.4.7 Moderna, Inc.
9.4.7.1 Company Overview
9.4.7.2 Financial Performance
9.4.7.3 Product Benchmarking
9.4.7.4 Strategic Initiatives
9.4.8 Sanofi
9.4.8.1 Company Overview
9.4.8.2 Financial Performance
9.4.8.3 Product Benchmarking
9.4.9.4 Strategic Initiatives
9.4.9 AstraZeneca
9.4.9.1 Company Overview
9.4.9.2 Financial Performance
9.4.9.3 Product Benchmarking
9.4.9.4 Strategic Initiatives
9.4.10 Bristol-Myers Squibb Company
9.4.9.1 Company Overview
9.4.9.2 Financial Performance
9.4.9.3 Product Benchmarking
9.4.9.4 Strategic Initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Global Cancer Vaccine Market, By Region, 2018 - 2030 (USD Million)
Table 4 Global Cancer Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 5 Global Cancer Vaccine Market, By Indication Type, 2018 - 2030 (USD Million)
Table 6 Global Cancer Vaccine Market, By Technology Type, 2018 - 2030 (USD Million)
Table 7 North America Cancer Vaccine Market, By Country, 2018 - 2030 (USD Million)
Table 8 North America Cancer Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 9 North America Cancer Vaccine Market, By Indication Type, 2018 - 2030 (USD Million)
Table 10 North America Cancer Vaccine Market, By Technology Type, 2018 - 2030 (USD Million)
Table 11 U.S. Cancer Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 12 U.S. Cancer Vaccine Market, By Indication Type, 2018 - 2030 (USD Million)
Table 13 U.S. Cancer Vaccine Market, By Technology Type, 2018 - 2030 (USD Million)
Table 14 Canada Cancer Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 15 Canada Cancer Vaccine Market, By Indication Type, 2018 - 2030 (USD Million)
Table 16 Canada Cancer Vaccine Market, By Technology Type, 2018 - 2030 (USD Million)
Table 17 Europe Cancer Vaccine Market, By Country, 2018 - 2030 (USD Million)
Table 18 Europe Cancer Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 19 Europe Cancer Vaccine Market, By Indication Type, 2018 - 2030 (USD Million)
Table 20 Europe Cancer Vaccine Market, By Technology Type, 2018 - 2030 (USD Million)
Table 21 UK Cancer Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 22 UK Cancer Vaccine Market, By Indication Type, 2018 - 2030 (USD Million)
Table 23 UK Cancer Vaccine Market, By Technology Type, 2018 - 2030 (USD Million)
Table 24 Germany Cancer Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 25 Germany Cancer Vaccine Market, By Indication Type, 2018 - 2030 (USD Million)
Table 26 Germany Cancer Vaccine Market, By Technology Type, 2018 - 2030 (USD Million)
Table 27 France Cancer Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 28 France Cancer Vaccine Market, By Indication Type, 2018 - 2030 (USD Million)
Table 29 France Cancer Vaccine Market, By Technology Type, 2018 - 2030 (USD Million)
Table 30 Italy Cancer Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 31 Italy Cancer Vaccine Market, By Indication Type, 2018 - 2030 (USD Million)
Table 32 Italy Cancer Vaccine Market, By Technology Type, 2018 - 2030 (USD Million)
Table 33 Spain Cancer Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 34 Spain Cancer Vaccine Market, By Indication Type, 2018 - 2030 (USD Million)
Table 35 Spain Cancer Vaccine Market, By Technology Type, 2018 - 2030 (USD Million)
Table 36 Denmark Cancer Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 37 Denmark Cancer Vaccine Market, By Indication Type, 2018 - 2030 (USD Million)
Table 38 Denmark Cancer Vaccine Market, By Technology Type, 2018 - 2030 (USD Million)
Table 39 Sweden Cancer Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 40 Sweden Cancer Vaccine Market, By Indication Type, 2018 - 2030 (USD Million)
Table 41 Sweden Cancer Vaccine Market, By Technology Type, 2018 - 2030 (USD Million)
Table 42 Norway Cancer Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 43 Norway Cancer Vaccine Market, By Indication Type, 2018 - 2030 (USD Million)
Table 44 Norway Cancer Vaccine Market, By Technology Type, 2018 - 2030 (USD Million)
Table 45 Asia Pacific Cancer Vaccine Market, By Country, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Cancer Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Cancer Vaccine Market, By Indication Type, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Cancer Vaccine Market, By Technology Type, 2018 - 2030 (USD Million)
Table 49 Japan Cancer Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 50 Japan Cancer Vaccine Market, By Indication Type, 2018 - 2030 (USD Million)
Table 51 Japan Cancer Vaccine Market, By Technology Type, 2018 - 2030 (USD Million)
Table 52 China Cancer Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 53 China Cancer Vaccine Market, By Indication Type, 2018 - 2030 (USD Million)
Table 54 China Cancer Vaccine Market, By Technology Type, 2018 - 2030 (USD Million)
Table 55 India Cancer Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 56 India Cancer Vaccine Market, By Indication Type, 2018 - 2030 (USD Million)
Table 57 India Cancer Vaccine Market, By Technology Type, 2018 - 2030 (USD Million)
Table 58 South Korea Cancer Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 59 South Korea Cancer Vaccine Market, By Indication Type, 2018 - 2030 (USD Million)
Table 60 South Korea Cancer Vaccine Market, By Technology Type, 2018 - 2030 (USD Million)
Table 61 Australia Cancer Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 62 Australia Cancer Vaccine Market, By Indication Type, 2018 - 2030 (USD Million)
Table 63 Australia Cancer Vaccine Market, By Technology Type, 2018 - 2030 (USD Million)
Table 64 Thailand Cancer Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 65 Thailand Cancer Vaccine Market, By Indication Type, 2018 - 2030 (USD Million)
Table 66 Thailand Cancer Vaccine Market, By Technology Type, 2018 - 2030 (USD Million)
Table 67 Latin America Cancer Vaccine Market, By Country, 2018 - 2030 (USD Million)
Table 68 Latin America Cancer Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 69 Latin America Cancer Vaccine Market, By Indication Type, 2018 - 2030 (USD Million)
Table 70 Latin America Cancer Vaccine Market, By Technology Type, 2018 - 2030 (USD Million)
Table 71 Brazil Cancer Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 72 Brazil Cancer Vaccine Market, By Indication Type, 2018 - 2030 (USD Million)
Table 73 Brazil Cancer Vaccine Market, By Technology Type, 2018 - 2030 (USD Million)
Table 74 Mexico Cancer Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 75 Mexico Cancer Vaccine Market, By Indication Type, 2018 - 2030 (USD Million)
Table 76 Mexico Cancer Vaccine Market, By Technology Type, 2018 - 2030 (USD Million)
Table 77 Argentina Cancer Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 78 Argentina Cancer Vaccine Market, By Indication Type, 2018 - 2030 (USD Million)
Table 79 Argentina Cancer Vaccine Market, By Technology Type, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa Cancer Vaccine Market, By Country, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa Cancer Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa Cancer Vaccine Market, By Indication Type, 2018 - 2030 (USD Million)
Table 83 Middle East & Africa Cancer Vaccine Market, By Technology Type, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia Cancer Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 85 Saudi Arabia Cancer Vaccine Market, By Indication Type, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia Cancer Vaccine Market, By Technology Type, 2018 - 2030 (USD Million)
Table 87 South Africa Cancer Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 88 South Africa Cancer Vaccine Market, By Indication Type, 2018 - 2030 (USD Million)
Table 89 South Africa Cancer Vaccine Market, By Technology Type, 2018 - 2030 (USD Million)
Table 90 UAE Cancer Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 91 UAE Cancer Vaccine Market, By Indication Type, 2018 - 2030 (USD Million)
Table 92 UAE Cancer Vaccine Market, By Technology Type, 2018 - 2030 (USD Million)
Table 93 Kuwait Cancer Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 94 Kuwait Cancer Vaccine Market, By Indication Type, 2018 - 2030 (USD Million)
Table 95 Kuwait Cancer Vaccine Market, By Technology Type, 2018 - 2030 (USD Million)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ がんワクチンの世界市場2023-2030：市場規模、シェア、動向分析(Cancer Vaccine Market Size, Share & Trends Analysis Report By Indication Type (Bladder, Cervical), By Vaccine Type (Preventive, Therapeutic), By Technology Type (Recombinant, Whole-cell), By Region, And Segment Forecasts, 2023 - 2030)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • インフルエンザワクチンの世界市場2024-2030：市場規模、シェア、動向分析
  • 世界のインフルエンザワクチン市場2023-2030：市場規模、シェア、動向分析
  • 呼吸器疾患ワクチンの世界市場2023-2030：市場規模、シェア、動向分析
  • ワクチンの世界市場2023-2030：市場規模、シェア、動向分析
  • がんバイオプシーの世界市場2023-2030：市場規模、シェア、動向分析

    • ◆H&Iグローバルリサーチのお客様（例）◆